ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Augmenter of Liver Regeneration (ALR) Protects Kidney from Ischemia/Reperfusion (I/R) Injury via Regulation of TLR4/MAPK Signaling Pathway

Li, Ying; Xiong, Yanying; Li, Huihui; Luo, Yan; Zhang, Ling; Zhang, Qin; Xiong, Weijian*; Tu, Haitao*广州中医药大学; 1
Journal of Immunology Research2022-8-9DOI: 10.1155/2022/6869730
5阅读
引用收藏
分享

摘要

Toll-like receptor 4 (TLR4) can mediate innate activation and inflammation, and it is typically expressed within the ischemic kidney. Augmenter of liver regeneration (ALR) acts as an immunoregulator with a high expression in the kidney induced by renal ischemia/reperfusion (I/R) injury. Exogenous ALR has indicated a role in protecting the kidney from I/R injury. The protective effect of ALR is due to the immune regulatory function which remains to be elucidated. In this study, rats induced by renal I/R were treated with recombinant human ALR (rhALR) and demonstrated that the animals were protected from kidney I/R injury, implying that the rhALR-treated rats had less tubular damage than those untreated rats. Meanwhile, tubular epithelial cell apoptosis, neutrophil (24 h) and macrophage (72 h) infiltration to tubulointerstitium, and levels of inflammatory cytokines were decreased considerably in the rhALR-treated rats as compared to control. Additionally, rhALR could downregulate mRNA expression of TLR4 endogenous ligands and restrain its activation in renal I/R injury rats. It has also been proved that anti-rhALR antibody blocked the inhibition of rhALR of the immune inflammatory response in hypoxia/reoxygenation (H/R) injury in vitro. In rhALR+anti-rhALR antibody-intervened H/R cells, the expression of inflammatory cytokines was upregulated compared with the rhALR-treated cells. Taken together, rhALR could regulate the TLR4 signaling pathway to relieve inflammatory response, thereby protecting renal I/R injury, indicating that ALR is likely to be introduced to develop novel immune therapies for renal I/R injury.

学科与关键词

关键词
ISCHEMIA-REPERFUSION INJURYENDOPLASMIC-RETICULUM STRESSOXIDATIVE STRESSTLR4AUTOPHAGYHEPATOPOIETININFLAMMATIONINVOLVEMENTEXPRESSIONRATS
相关
加载中…
  • RP105 protects against ischemic and septic acute kidney injury via suppressing TLR4/NF-κB signaling pathways
    Zhu, Jiefu; Zhang, Yafei; Shi, Lang; Xia, Yao; Zha, Hongchu; Li, Huimin; Song, Zhixia*International Immunopharmacology, 2022, 109.被引 7
  • TGF-β1 peptide-based inhibitor P144 ameliorates renal fibrosis after ischemia-reperfusion injury by modulating alternatively activated macrophages
    Li, Delun; Zhang, Jian; Yuan, Siyu; Wang, Chao; Chang, Jiakai; Tong, Yan; Liu, Ran; Sang, Tian; Li, Lili; Li, Jijun; Ouyang, Qing*; Chen, Xiangmei*Cell Proliferation, 2022, 55(10): e13299.被引 6
  • IKK1 aggravates ischemia-reperfusion kidney injury by promoting the differentiation of effector T cells
    Song, Ning; Xu, Yang; Paust, Hans-Joachim; Panzer, Ulf; de las Noriega, Maria Mercedes; Guo, Linlin; Renne, Thomas; Huang, Jiabin; Meng, Xianglin; Zhao, Mingyan*; Thaiss, Friedrich*Cellular and Molecular Life Sciences, 2023, 80(5): 125.
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Immunology Research
发表日期
2022-08-09
卷期
第 2022 卷
页码
6869730
DOI
10.1155/2022/6869730
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China; [81904012]

作者

  • L

    Li, Ying (第一作者)

    2 · chongqing med univ · chongqing hosp tradit chinese med

  • X

    Xiong, Yanying

    chongqing hosp tradit chinese med

查看全部 8 位作者收起作者
  • L

    Li, Huihui

    chongqing hosp tradit chinese med

  • L

    Luo, Yan

    chongqing hosp tradit chinese med

  • Z

    Zhang, Ling

    chongqing hosp tradit chinese med

  • Z

    Zhang, Qin

    chongqing hosp tradit chinese med

  • X

    Xiong, Weijian (通讯)

    chongqing hosp tradit chinese med

  • T

    Tu, Haitao (通讯)

    1 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417